Overcoming Operational and Regulatory Challenges in Autologous Cell-Therapy Facilities

July 01, 2020

Manufacturers must address scale-out challenges of autologous cell therapy for commercial manufacturing.

Eliminating Residual Impurities Starts with a Strategic Plan

July 01, 2020

Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.

New Cybersecurity Features Protect Facilities with Remote Operations

June 29, 2020

Honeywell Forge Cybersecurity Suite’s improved industrial-grade remote access and added protection and risk monitoring aids remote operations.

Symbiosis, AstraZeneca Sign Supply Agreement for Sterile Vaccine Manufacture

June 25, 2020

Symbiosis Pharmaceutical Services has signed a supply agreement with AstraZeneca for the sterile manufacture of AZD1222, a COVID-19 recombinant adenovirus vaccine, to be used in clinical trials.

Inovio to Scale-Up Manufacture of Intradermal Delivery Device for its COVID-19 Vaccine

June 24, 2020

Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.

Corning Expands Glass Vial Capacity

June 17, 2020

Corning will use BARDA funding to expand US manufacturing capacity for pharmaceutical tubing and vials made from Valor glass.

Cobra Biologics to Manufacture AstraZeneca’s COVID-19 Vaccine Candidate

June 17, 2020

Cobra Biologics has signed a supply agreement to provide GMP manufacturing for AstraZeneca’s AZD1222 COVID-19 vaccine candidate.

Oxford Biomedica Signs Agreement with Vaccines Manufacturing and Innovation Centre

June 12, 2020

Oxford Biomedica, has signed a collaboration agreement with the not-for-profit organization, the Vaccines Manufacturing and Innovation Centre, to provide the UK with its first strategic vaccine development and advanced manufacturing capability.

Lonza, Anthos Therapeutics Partner on Anti-coagulant Biologic Abelacimab

June 11, 2020

The companies have entered into a development and manufacturing agreement for Anthos Therapeutics’ abelacimab for treating thrombotic disorders.

Siemens and Exyte Collaborate to Provide Modular Biopharma Facilities

June 09, 2020

Siemens and Exyte partner for fast-track construction of modular, automated, digitalized biopharmaceutical facilities.